The New England journal of medicine, 2018-05, Vol.378 (18), p.1671-1680
2018
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
- Ist Teil von
- The New England journal of medicine, 2018-05, Vol.378 (18), p.1671-1680
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2018
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- The frequency of COPD exacerbations during treatment with a triple inhaler — delivering a long-acting beta-agonist (LABA), a long-acting muscarinic antagonist (LAMA), and an inhaled glucocorticoid — was compared with that with a LABA–LAMA or LABA–inhaled glucocorticoid.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1713901Titel-ID: cdi_hal_primary_oai_HAL_hal_02056333v1
- Format
- –
- Schlagworte
- Acetylcholine receptors (muscarinic), Administration, Inhalation, Adrenergic beta-Agonists - administration & dosage, Adrenergic beta-Agonists - adverse effects, Adult, Aged, Androstadienes - administration & dosage, Benzyl Alcohols - administration & dosage, Bronchodilator Agents - administration & dosage, Bronchodilator Agents - adverse effects, Chlorobenzenes - administration & dosage, Chronic obstructive pulmonary disease, Critical care, Double-Blind Method, Drug Administration Schedule, Drug Combinations, Drug dosages, Dyspnea - drug therapy, Dyspnea - etiology, Female, Fluticasone, Glucocorticoids, Glucocorticoids - administration & dosage, Glucocorticoids - adverse effects, Hospitalization - statistics & numerical data, Hospitals, Human health and pathology, Humans, Inhalers, Intention to Treat Analysis, Life Sciences, Lung diseases, Male, Medicine, Middle Aged, Muscarinic Antagonists - administration & dosage, Muscarinic Antagonists - adverse effects, Obstructive lung disease, Patients, Pneumonia, Population, Pulmonary Disease, Chronic Obstructive - complications, Pulmonary Disease, Chronic Obstructive - drug therapy, Pulmonology and respiratory tract, Quality of Life, Quinuclidines - administration & dosage